HighMark Wealth Management’s Bioventus BVS Stock Holding History

HighMark Wealth Management’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,500	Closed	-$10K	–	597
2025 Q3	$10K	Hold	1,500	–	–	﹤0.01%	300
2025 Q2	$9.93K	Hold	1,500	–	–	﹤0.01%	312
2025 Q1	$13.7K	Hold	1,500	–	–	0.01%	239
2024 Q4	$15.8K	Hold	1,500	–	–	0.01%	228
2024 Q3	$17.9K	Sell	1,500 -3,000	-67%	-$25.9K	0.01%	216
2024 Q2	$25.9K	Hold	4,500	–	–	0.02%	181
2024 Q1	$23.4K	Buy	+4,500	New	+$22K	0.01%	187

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

JIC

Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

HighMark Wealth Management's BVS Position: Q4 2025 in Review

HighMark Wealth Management sold out of Bioventus (BVS) in Q4 2025, closing a stake of 1,500 shares — an estimated $10K sold.

HighMark Wealth Management first reported a position in BVS in Q1 2024 and held it in 7 quarters. The position peaked at $25.9K in Q2 2024. 148 funds tracked by Wall St. Rank hold BVS as of Q4 2025.

HighMark Wealth Management reported no remaining Bioventus position as of Q4 2025 after selling out during the quarter.
HighMark Wealth Management sold 1,500 Bioventus shares in Q4 2025, an estimated $10K.
HighMark Wealth Management first reported a position in Bioventus in Q1 2024 and held it in 7 quarters.
HighMark Wealth Management's Bioventus position peaked at $25.9K in Q2 2024.
148 funds tracked by Wall St. Rank held Bioventus as of Q4 2025.

Based on HighMark Wealth Management's 13F filing for Q4 2025, filed 5 Feb 2026.